Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Journal of the American Heart Association|April 19, 2021
Effect of Increased Potassium Intake on Adrenal Cortical and Cardiovascular Responses to Angiotensin II: A Randomized Crossover StudyRasmus Dreier, Ulrik B Andersen, Julie L Forman, et al.BMC Nephrology|May 5, 2018
The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity: a multicenter randomized, double-blind, clinical trial (the SPIREN trial)Line Aas Mortensen, Helle C Thiesson, Birgitte Tougaard, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|January 31, 2015
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with abdominal aortic aneurysms: nation-wide cohort studyKarl Emil Kristensen, Christian Torp-Pedersen, Gunnar Hilmar Gislason, et al.Basic & Clinical Pharmacology & Toxicology|May 17, 2006
Correlations between calcineurin phosphatase inhibition and cyclosporine metabolites concentrations in kidney transplant recipients: implications for immunoassaysNikolaos Karamperis, Pernille Bundgaard Koefoed-Nielsen, Pia Brahe, et al.Plos One|December 4, 2015
Pharmacogenetic Risk Stratification in Angiotensin-Converting Enzyme Inhibitor-Treated Patients with Congestive Heart Failure: A Retrospective Cohort StudyKarl Emil Nelveg-Kristensen, Majbritt Busk Madsen, Christian Torp-Pedersen, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2017
Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes-a Danish population-based cohort studyReimar W Thomsen, Sia K Nicolaisen, Pål Hasvold, et al.Plos One|September 24, 2016
Pharmacodynamic Impact of Carboxylesterase 1 Gene Variants in Patients with Congestive Heart Failure Treated with Angiotensin-Converting Enzyme InhibitorsKarl Emil Nelveg-Kristensen, Peter Bie, Laura Ferrero, et al.Nephron|September 12, 2018
Temporal Regulation of Glomerular and Cortical Tubulointerstitial Genes Involved in the Development of Nephrotoxic Serum NephritisMaria E Ougaard, Frederikke E Sembach, Peter H Kvist, et al.Journal of the American Heart Association|May 24, 2018
Elevated Potassium Levels in Patients With Congestive Heart Failure: Occurrence, Risk Factors, and Clinical Outcomes: A Danish Population-Based Cohort StudyReimar Wernich Thomsen, Sia Kromann Nicolaisen, Pål Hasvold, et al.Pharmacogenetics and Genomics|January 14, 2016
Prognostic impact of carboxylesterase 1 gene variants in patients with congestive heart failure treated with angiotensin-converting enzyme inhibitorsKarl E Nelveg-Kristensen, Majbritt B Madsen, Christian Torp-Pedersen, et al.Pageof 3